Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PharmacofMRI [functional magnetic resonance imaging] of Anxiolytic Medications (Pregabalin).

Trial Profile

PharmacofMRI [functional magnetic resonance imaging] of Anxiolytic Medications (Pregabalin).

Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2011

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain; Postherpetic neuralgia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Jun 2011 Results published in Neuropsychopharmacology.
    • 20 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top